EP17.33: Clinical utility of first trimester combined screening for gestational diabetes using a point of care system

Ähnliche Einträge

• EP17.54: Assessment of the angiogenic ratio versus glycosylated fibronectin in predicting adverse neonatal outcome in women with suspected pre‐eclampsia
  von: Y. Wah, et al.
  Veröffentlicht: (2024)
• EP17.06: Inter‐manufacturer assessment of the diagnostic performance of angiogenic ratio versus glycosylated fibronectin in women with suspected pre‐eclampsia
  von: Y. Wah, et al.
  Veröffentlicht: (2024)
• OP13.05: Assessment of the angiogenic ratio versus glycosylated fibronectin in predicting adverse maternal outcome in women with suspected pre‐eclampsia
  von: Y. Wah, et al.
  Veröffentlicht: (2024)
• Evaluation of screening performance of first‐trimester competing‐risks prediction model for small‐for‐gestational age in Asian population
  von: L. Nguyen‐Hoang, et al.
  Veröffentlicht: (2024)
• OP15.04: Validation of the first trimester machine learning model for predicting pre‐eclampsia in Asian populations
  von: L. Nguyen Hoang, et al.
  Veröffentlicht: (2024)